Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Haematologica
|
August 13, 2013
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
David Siegel, Thomas Martin, Ajay Nooka, et al.
Transfusion
|
September 3, 2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial
Neera Jagirdar, R Donald Harvey, Ajay Nooka, et al.
American Journal of Hematology
|
March 27, 2025
Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta-Analysis
Joshua Richter, Ajay Nooka, Paula Rodríguez-Otero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 15, 2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma
R Donald Harvey, Jonathan L Kaufman, Heather R Johnson, et al.
Blood Cancer Discovery
|
June 28, 2021
Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcare
Nicole Gormley, Lola Fashoyin-Aje, Trevan Locke, et al.
Oncology
|
September 21, 2013
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma
Ahmed O Kaseb, Mohamed Shama, Ibrahim Halil Sahin, et al.
Southern Medical Journal
|
August 2, 2014
Incidence and geographic distribution of adult acute leukemia in the state of Georgia
Fuad El Rassi, Kevin C Ward, Christopher R Flowers, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma
Rajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 19, 2008
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
Ana O Hoff, Béla B Toth, Kadri Altundag, et al.
British Journal of Haematology
|
May 28, 2021
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
Hang Quach, Ajay Nooka, Olga Samoylova, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Haematologica
|
August 13, 2013
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
David Siegel, Thomas Martin, Ajay Nooka, et al.
Transfusion
|
September 3, 2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial
Neera Jagirdar, R Donald Harvey, Ajay Nooka, et al.
American Journal of Hematology
|
March 27, 2025
Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta-Analysis
Joshua Richter, Ajay Nooka, Paula Rodríguez-Otero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 15, 2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma
R Donald Harvey, Jonathan L Kaufman, Heather R Johnson, et al.
Blood Cancer Discovery
|
June 28, 2021
Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcare
Nicole Gormley, Lola Fashoyin-Aje, Trevan Locke, et al.
Oncology
|
September 21, 2013
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma
Ahmed O Kaseb, Mohamed Shama, Ibrahim Halil Sahin, et al.
Southern Medical Journal
|
August 2, 2014
Incidence and geographic distribution of adult acute leukemia in the state of Georgia
Fuad El Rassi, Kevin C Ward, Christopher R Flowers, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma
Rajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 19, 2008
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
Ana O Hoff, Béla B Toth, Kadri Altundag, et al.
British Journal of Haematology
|
May 28, 2021
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
Hang Quach, Ajay Nooka, Olga Samoylova, et al.
Page
of 5